Cargando…
A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study
OBJECTIVE: To evaluate the effectiveness of two technology-enhanced interventions for diabetes prevention among adults at risk for developing diabetes in a primary care setting. METHODS: The DiaBEAT-it study employed a hybrid 2-group preference (Choice) and 3-group randomized controlled (RCT) design...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998510/ https://www.ncbi.nlm.nih.gov/pubmed/36908422 http://dx.doi.org/10.3389/fpubh.2023.1000162 |
_version_ | 1784903479797481472 |
---|---|
author | Almeida, Fabio A. You, Wen Brito, Fabiana A. Alves, Thais F. Goessl, Cody Wall, Sarah S. Seidel, Richard W. Davy, Brenda M. Greenawald, Mark H. Hill, Jennie L. Estabrooks, Paul A. |
author_facet | Almeida, Fabio A. You, Wen Brito, Fabiana A. Alves, Thais F. Goessl, Cody Wall, Sarah S. Seidel, Richard W. Davy, Brenda M. Greenawald, Mark H. Hill, Jennie L. Estabrooks, Paul A. |
author_sort | Almeida, Fabio A. |
collection | PubMed |
description | OBJECTIVE: To evaluate the effectiveness of two technology-enhanced interventions for diabetes prevention among adults at risk for developing diabetes in a primary care setting. METHODS: The DiaBEAT-it study employed a hybrid 2-group preference (Choice) and 3-group randomized controlled (RCT) design. This paper presents weight related primary outcomes of the RCT arm. Patients from Southwest Virginia were identified through the Carilion Clinic electronic health records. Eligible participants (18 and older, BMI ≥ 25, no Type 2 Diabetes) were randomized to either Choice (n = 264) or RCT (n = 334). RCT individuals were further randomized to one of three groups: (1) a 2-h small group class to help patients develop a personal action plan to prevent diabetes (SC, n = 117); (2) a 2-h small group class plus automated telephone calls using an interactive voice response system (IVR) to help participants initiate weight loss through a healthful diet and regular physical activity (Class/IVR, n = 110); or (3) a DVD with same content as the class plus the same IVR calls over a period of 12 months (DVD/IVR, n = 107). RESULTS: Of the 334 participants that were randomized, 232 (69%) had study measured weights at 6 months, 221 (66%) at 12 months, and 208 (62%) at 18 months. Class/IVR participants were less likely to complete weight measures than SC or DVD/IVR. Intention to treat analyses, controlling for gender, race, age and baseline BMI, showed that DVD/IVR and Class/IVR led to reductions in BMI at 6 (DVD/IVR −0.94, p < 0.001; Class/IVR −0.70, p < 0.01), 12 (DVD/IVR −0.88, p < 0.001; Class/IVR-0.82, p < 0.001) and 18 (DVD/IVR −0.78, p < 0.001; Class/IVR −0.58, p < 0.01) months. All three groups showed a significant number of participants losing at least 5% of their body weight at 12 months (DVD/IVR 26.87%; Class/IVR 21.62%; SC 16.85%). When comparing groups, DVD/IVR were significantly more likely to decrease BMI at 6 months (p < 0.05) and maintain the reduction at 18 months (p < 0.05) when compared to SC. There were no differences between the other groups. CONCLUSIONS: The DiaBEAT-it interventions show promise in responding to the need for scalable, effective methods to manage obesity and prevent diabetes in primary care settings that do not over burden primary care clinics and providers. REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT02162901, identifier: NCT02162901. |
format | Online Article Text |
id | pubmed-9998510 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99985102023-03-11 A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study Almeida, Fabio A. You, Wen Brito, Fabiana A. Alves, Thais F. Goessl, Cody Wall, Sarah S. Seidel, Richard W. Davy, Brenda M. Greenawald, Mark H. Hill, Jennie L. Estabrooks, Paul A. Front Public Health Public Health OBJECTIVE: To evaluate the effectiveness of two technology-enhanced interventions for diabetes prevention among adults at risk for developing diabetes in a primary care setting. METHODS: The DiaBEAT-it study employed a hybrid 2-group preference (Choice) and 3-group randomized controlled (RCT) design. This paper presents weight related primary outcomes of the RCT arm. Patients from Southwest Virginia were identified through the Carilion Clinic electronic health records. Eligible participants (18 and older, BMI ≥ 25, no Type 2 Diabetes) were randomized to either Choice (n = 264) or RCT (n = 334). RCT individuals were further randomized to one of three groups: (1) a 2-h small group class to help patients develop a personal action plan to prevent diabetes (SC, n = 117); (2) a 2-h small group class plus automated telephone calls using an interactive voice response system (IVR) to help participants initiate weight loss through a healthful diet and regular physical activity (Class/IVR, n = 110); or (3) a DVD with same content as the class plus the same IVR calls over a period of 12 months (DVD/IVR, n = 107). RESULTS: Of the 334 participants that were randomized, 232 (69%) had study measured weights at 6 months, 221 (66%) at 12 months, and 208 (62%) at 18 months. Class/IVR participants were less likely to complete weight measures than SC or DVD/IVR. Intention to treat analyses, controlling for gender, race, age and baseline BMI, showed that DVD/IVR and Class/IVR led to reductions in BMI at 6 (DVD/IVR −0.94, p < 0.001; Class/IVR −0.70, p < 0.01), 12 (DVD/IVR −0.88, p < 0.001; Class/IVR-0.82, p < 0.001) and 18 (DVD/IVR −0.78, p < 0.001; Class/IVR −0.58, p < 0.01) months. All three groups showed a significant number of participants losing at least 5% of their body weight at 12 months (DVD/IVR 26.87%; Class/IVR 21.62%; SC 16.85%). When comparing groups, DVD/IVR were significantly more likely to decrease BMI at 6 months (p < 0.05) and maintain the reduction at 18 months (p < 0.05) when compared to SC. There were no differences between the other groups. CONCLUSIONS: The DiaBEAT-it interventions show promise in responding to the need for scalable, effective methods to manage obesity and prevent diabetes in primary care settings that do not over burden primary care clinics and providers. REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT02162901, identifier: NCT02162901. Frontiers Media S.A. 2023-02-24 /pmc/articles/PMC9998510/ /pubmed/36908422 http://dx.doi.org/10.3389/fpubh.2023.1000162 Text en Copyright © 2023 Almeida, You, Brito, Alves, Goessl, Wall, Seidel, Davy, Greenawald, Hill and Estabrooks. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Public Health Almeida, Fabio A. You, Wen Brito, Fabiana A. Alves, Thais F. Goessl, Cody Wall, Sarah S. Seidel, Richard W. Davy, Brenda M. Greenawald, Mark H. Hill, Jennie L. Estabrooks, Paul A. A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title | A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title_full | A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title_fullStr | A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title_full_unstemmed | A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title_short | A randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: The DiaBEAT-it study |
title_sort | randomized controlled trial to test the effectiveness of two technology-enhanced diabetes prevention programs in primary care: the diabeat-it study |
topic | Public Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998510/ https://www.ncbi.nlm.nih.gov/pubmed/36908422 http://dx.doi.org/10.3389/fpubh.2023.1000162 |
work_keys_str_mv | AT almeidafabioa arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT youwen arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT britofabianaa arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT alvesthaisf arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT goesslcody arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT wallsarahs arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT seidelrichardw arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT davybrendam arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT greenawaldmarkh arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT hilljenniel arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT estabrookspaula arandomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT almeidafabioa randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT youwen randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT britofabianaa randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT alvesthaisf randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT goesslcody randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT wallsarahs randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT seidelrichardw randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT davybrendam randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT greenawaldmarkh randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT hilljenniel randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy AT estabrookspaula randomizedcontrolledtrialtotesttheeffectivenessoftwotechnologyenhanceddiabetespreventionprogramsinprimarycarethediabeatitstudy |